Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex

Stamford, CT, United States:   Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces

READ MORE

Dicot Pharma provides an operational update

Uppsala, Sweden, September 17, 2024. Following the successful outcome of Dicot Pharma’s rights issue, an operational update is being presented today.

READ MORE

Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients

Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in

READ MORE

#24-87 New last day of trading in Coegin Pharma TO3

  Trading in Coegin Pharma TO3 will be resumed tomorrow September 13, 2024. The previously announced last day of trading

READ MORE